ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,003 | +332.3% | 146,454 | +892.7% | 0.01% | +233.3% |
| Q4 2022 | $232 | -100.0% | 14,753 | -49.1% | 0.00% | -50.0% |
| Q2 2021 | $509,000 | -85.7% | 28,975 | -79.4% | 0.01% | -88.5% |
| Q1 2021 | $3,550,000 | +146.4% | 140,855 | -36.7% | 0.05% | +271.4% |
| Q4 2020 | $1,441,000 | – | 222,648 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 1,769,785 | $1,911,000 | 0.69% |
| Telemetry Investments, L.L.C. | 214,593 | $232,000 | 0.67% |
| Aisling Capital Management LP | 634,455 | $685,000 | 0.36% |
| Broadfin Capital, LLC | 1,620,000 | $1,750,000 | 0.32% |
| MFN Partners Management, LP | 1,500,000 | $1,620,000 | 0.24% |
| Sofinnova Investments, Inc. | 1,911,573 | $2,064,000 | 0.19% |
| Rock Springs Capital Management LP | 2,974,754 | $3,213,000 | 0.13% |
| Alambic Investment Management, L.P. | 150,636 | $163,000 | 0.12% |
| Cormorant Asset Management, LP | 250,000 | $270,000 | 0.02% |
| Man Group plc | 3,734,793 | $4,034,000 | 0.02% |